E-cadherin and periostin in early detection and progression of diabetic nephropathy: epithelial-to-mesenchymal transition
dc.Affiliation | October University for modern sciences and Arts (MSA) | |
dc.contributor.author | El-Dawla, Nada M. Qamar | |
dc.contributor.author | Sallam, Al-Aliaa M | |
dc.contributor.author | El-Hefnawy, Mohamed H | |
dc.contributor.author | El-Mesallamy, Hala O | |
dc.date.accessioned | 2019-11-14T14:41:00Z | |
dc.date.available | 2019-11-14T14:41:00Z | |
dc.date.issued | 2019-08 | |
dc.description | Accession Number: WOS:000475963400009 | en_US |
dc.description.abstract | Results Concerning E-cadherin levels, in comparison to control group, there were significantly decreased in all groups (0.94, 0.52, and 0.14 ng/mL in normoalbuminuria, microalbuminuria, and macroalbuminuria groups; respectively). For periostin levels, nonsignificant increase in normoalbuminuria (0.32 ng/mL) than control group (0.3 ng/mL) was observed. There was a significant increase in other groups with the highest values in macroalbuminuria group (1.66 ng/mL). E-cadherin and periostin were correlated with each other (r = -0.353, P < 0.001). UACR was negatively correlated with E-cadherin and positively correlated with periostin. ROC curve analyses showed that the AUC to diagnose established microalbuminuria using E-cadherin was 0.998 (95% CI 0.932-1), and using periostin was 0.833 (95% CI 0.709-0.919). | en_US |
dc.description.uri | https://www.scimagojr.com/journalsearch.php?q=19417&tip=sid&clean=0 | |
dc.identifier.doi | https://doi.org/ | |
dc.identifier.issn | 1342-1751 | |
dc.identifier.other | https://doi.org/ | |
dc.identifier.uri | https://cutt.ly/peGPvNL | |
dc.language.iso | en_US | en_US |
dc.publisher | Springer | en_US |
dc.relation.ispartofseries | CLINICAL AND EXPERIMENTAL NEPHROLOGY;Volume: 23 Issue: 8 Pages: 1050-1057 | |
dc.relation.uri | https://cutt.ly/teDysru | |
dc.subject | TISSUE | en_US |
dc.subject | EXPRESSION | en_US |
dc.subject | MECHANISMS | en_US |
dc.subject | IDENTIFICATION | en_US |
dc.subject | BIOMARKER | en_US |
dc.subject | Plus:RENAL INJURY | en_US |
dc.subject | Periostin | en_US |
dc.subject | EMT | en_US |
dc.subject | E-cadherin | en_US |
dc.subject | Diabetic nephropathy | en_US |
dc.title | E-cadherin and periostin in early detection and progression of diabetic nephropathy: epithelial-to-mesenchymal transition | en_US |
dc.type | Article | en_US |